Experience with mass screening for lung carcinoma

Area of Science:

• Oncology
• Thoracic Surgery
• Public Health

Background:

• Lung cancer survival rates historically varied significantly by stage.
• Early diagnosis and surgical intervention are crucial for improving patient outcomes.
• Mediastinoscopy is a diagnostic procedure for assessing lymph node involvement in lung cancer.

Purpose of the Study:

• To evaluate the 5-year survival rates of primary lung cancer patients.
• To assess the impact of tumor stage and histology on survival.
• To determine the resectability and perioperative mortality associated with lung cancer surgery.

Main Methods:

• Retrospective analysis of 128 primary lung cancer patients diagnosed between 1970 and 1976.
• Inclusion of mediastinoscopy in all patients, with monitoring for mortality and morbidity.
• TNM classification used to categorize disease stage (Stage I, II, III).

Main Results:

• The 5-year survival rate for asymptomatic Stage I squamous cell carcinoma patients was 46.3%.
• Stage II and III patients had significantly lower 5-year survival rates of 9.5% and 0%, respectively.
• The resectability rate was 58.6%, with a perioperative mortality of 7.5%.

Conclusions:

• Early-stage lung cancer, particularly squamous cell carcinoma, offers a better prognosis.
• Mediastinoscopy can be performed with acceptable safety in lung cancer staging.
• The findings support the need for continued evaluation of lung cancer mass screening programs.